Unicity International launches genomeceuticals range of products in India

US-based Unicity International, has launched gene controlling genomeceutical range of products in India. Unicity uses  genomeceutical  technology in its products to support proper gene expression, which helps maintain healthy body function at their most basic levels.

Genomeceutical is a patent-pending technology, whereby certain secondary metabolites found in nature can help maintain the gene response whenever needed by the body and help maintain overall metabolic health. Unicity is currently researching an extensive range of products by leveraging this technology.

Speaking on the launch of Unicity’s Neigeneskin restoration system, Dr Dan Gubler, Chief Scientific Officer, Unicity, said, "Unicity has researched the use of premium extracts that control gene response and produce collagen to such stimuli while not only preventing further degeneration but also accentuating effective skin restoration. We have pioneered this as our first genomeceutical product. Research is underway to apply this technology to other areas of body care."